There’s good news for Fairfax County and the Sully District in particular. Trident Systems is investing $3.7 million to expand capacity at its operation in Chantilly for the production of space ...

MIRV demonstrated significant efficacy in platinum-resistant ovarian cancer, especially with high FRα expression, showing improved PFS and ORR. Combination regimens with MIRV, such as with bevacizumab ...

MSI has launched a new variant of the MPG Trident AS Mini Gaming PC in the Chinese market, expanding its compact desktop lineup with updated hardware and improved GPU options. The new configuration ...

A very short while ago, British bike maker Triumph committed to releasing no less than 29 new and updated bikes over the next six months. That's a gargantuan effort the likes of which I don't remember ...

Triumph's making it even harder to choose a naked steed for the streets from its stable, with the introduction of the Trident 800. It's the capable Trident 660's bolder sibling with more power and ...

All across baseball the past few seasons, we've seen teams get creative with their home run celebrations in the dugout. And, of course, props are often involved. No team arguably has a cooler home run ...

Maritime systems provider Trident Maritime Systems, a portfolio company of J.F. Lehman & Co., has announced the sale of Trident Maritime Systems UK and its subsidiaries, including Aeronautical & ...

The MIRV represents the culmination of a certain Cold War logic: the notion that security can be found in fielding such an overwhelming force that retaliation becomes mathematically inevitable. The ...

Triumph Motorcycles is working to diversify its product portfolio for the global market with the Trident 800. The Triumph Trident 800 has been snapped testing in Spain, hinting at its launch to be ...

Every investor in Trident Digital Tech Holdings Ltd (NASDAQ:TDTH) should be aware of the most powerful shareholder groups. We can see that individual insiders own the lion's share in the company with ...

New analyses of the PICCOLO trial provided evidence of the efficacy of mirvetuximab soravtansine-gynx (MIRV) in patients with platinum-sensitive ovarian cancer, but also that ocular toxicity is a ...